Renalytix PLC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OQB
Renalytix reports significant progress in commercializing its KidneyIntelX test, including FDA authorization, Medicare coverage, and cost reductions, projecting profitability within two years.